BIOATLA Trademark

Trademark Overview

On Thursday, January 18, 2024, a trademark application was filed for BIOATLA with the United States Patent and Trademark Office. The USPTO has given the BIOATLA trademark a serial number of 98364081. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, May 14, 2026. This trademark is owned by BioAtla, Inc.. The BIOATLA trademark is filed in the Pharmaceutical Products category with the following description:

Biological and pharmaceutical preparations for the treatment of age-related diseases and cancer
bioatla

General Information

Serial Number98364081
Word MarkBIOATLA
Filing DateThursday, January 18, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, May 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2026

Trademark Statements

Goods and ServicesBiological and pharmaceutical preparations for the treatment of age-related diseases and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code005
First Use Anywhere DateFriday, April 26, 2013
First Use In Commerce DateTuesday, February 27, 2018

Trademark Owner History

Party NameBioAtla, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events

Event DateEvent Description
Thursday, January 18, 2024NEW APPLICATION ENTERED
Friday, May 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 14, 2024ASSIGNED TO EXAMINER
Thursday, August 15, 2024SUSPENSION LETTER WRITTEN
Thursday, August 15, 2024LETTER OF SUSPENSION E-MAILED
Thursday, August 15, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, February 16, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, March 4, 2025SUSPENSION LETTER WRITTEN
Tuesday, March 4, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, March 4, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 5, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, September 30, 2025NON-FINAL ACTION WRITTEN
Tuesday, September 30, 2025NON-FINAL ACTION E-MAILED
Tuesday, September 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 2, 2026SUSPENSION LETTER WRITTEN
Friday, January 2, 2026LETTER OF SUSPENSION E-MAILED
Friday, January 2, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 6, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 6, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 7, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

bioatla diseases cancer related treatment pharmaceutical preparations biological